Table 3.
Primary and secondary outcomes.
| Illness | Intervention Group | Control Group |
Absolute Incidence Rate Difference | 95%-CI | p-Value | Relative Incidence Rate |
95%-CI | p-Value |
|---|---|---|---|---|---|---|---|---|
| Incidence Rate | Incidence Rate | |||||||
| All ILI | 6.104 × 10−5 | 2.288 × 10−4 | −1.677 × 10−4 | −3.025 × 10−4 to −3.3 × 10−5 |
0.0147 | 2.668 × 10−1 | 5.456 × 10−2 to 7.913 × 10−1 |
0.0060 |
| COVID-19 ILI | 0.0 | 4.181 × 10−5 | −4.181 × 10−5 | −9.897 × 10−5 to 1.536 × 10−5 |
0.1517 | N/A | N/A | N/A |
| Non-COVID-19 ILI | 6.104 × 10−5 | 1.916 × 10−4 | −1.306 × 10−4 | −2.541 × 10−4 to −7.1 × 10−6 |
0.0382 | 3.186 × 10−1 | 6.503 × 10−2 to 9.474 × 10−1 |
0.0229 |
Incidence rates are per person-day and relative incidence rate uses control group as reference; CI—Confidence Interval; ILI—Influenza-Like Illness.